Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Daiichi Sankyo
Julphar
Argus Health
Harvard Business School
McKinsey
Moodys
Deloitte

Generated: July 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018735

« Back to Dashboard

NDA 018735 describes ISOVUE-M 300, which is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. Additional details are available on the ISOVUE-M 300 profile page.

The generic ingredient in ISOVUE-M 300 is iopamidol. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopamidol profile page.
Summary for 018735
Tradename:ISOVUE-M 300
Applicant:Bracco
Ingredient:iopamidol
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018735
Mechanism of ActionX-Ray Contrast Activity
Medical Subject Heading (MeSH) Categories for 018735
Suppliers and Packaging for NDA: 018735
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ISOVUE-128 iopamidol INJECTABLE;INJECTION 018735 NDA BRACCO DIAGNOSTICS INC 0270-1314 N 0270-1314-15
ISOVUE-128 iopamidol INJECTABLE;INJECTION 018735 NDA BRACCO DIAGNOSTICS INC 0270-1314 N 0270-1314-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength41%
Approval Date:Dec 31, 1985TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength61%
Approval Date:Dec 31, 1985TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength76%
Approval Date:Dec 31, 1985TE:APRLD:Yes

Expired US Patents for NDA 018735

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco ISOVUE-250 iopamidol INJECTABLE;INJECTION 018735-007 Jul 6, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Bracco ISOVUE-M 200 iopamidol INJECTABLE;INJECTION 018735-001 Dec 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Bracco ISOVUE-370 iopamidol INJECTABLE;INJECTION 018735-003 Dec 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Bracco ISOVUE-M 300 iopamidol INJECTABLE;INJECTION 018735-004 Dec 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
Cipla
Federal Trade Commission
Farmers Insurance
Teva
Moodys
US Department of Justice
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.